Why Unum Therapeutics Is Trading Higher Today

Unum Therapeutics UMRX shares are trading higher on Friday after the company's 13D filing from Fairmount Funds disclosed a 19.99% active stake.

Unum Therapeutics Inc is a U.S.-based clinical-stage biopharmaceutical company. It is focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer.

Unum Therapeutics shares were trading up 7.81% at $3.24 at the time of publication on Friday. The stock has a 52-week high of $3.72 and a 52-week low of 30 cents.